rolofylline has been researched along with Dyspnea in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albert, NM; Butler, J; Carson, PE; Collins, SP; Colvin-Adams, M; Dimarco, JP; Ezekowitz, JA; Fang, JC; Givertz, MM; Hernandez, AF; Hershberger, RE; Katz, SD; Krishnamani, R; Rogers, JG; Spertus, JA; Starling, RC; Stevenson, WG; Stough, WG; Sweitzer, NK; Tang, WH; Teerlink, JR; Walsh, MN; Westlake Canary, CA | 1 |
Bloomfield, DM; Cleland, JG; Cotter, G; Damman, K; Davison, B; Dittrich, HC; Fiuzat, M; Givertz, MM; Hillege, HL; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Valente, MA; Van Veldhuisen, DJ; Voors, AA | 1 |
Bloomfield, DM; Cotter, G; Dittrich, HC; Massie, BM; Metra, M; O'Connor, CM; Weatherley, BD | 1 |
Cleland, JG; Cotter, G; Dittrich, HC; Givertz, MM; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Voors, AA; Weatherley, BD | 1 |
Gheorghiade, M; Ruschitzka, F | 1 |
Bloomfield, DM; Cleland, JG; Cotter, G; Davison, BA; DeLucca, P; Dittrich, H; Givertz, MM; Jia, G; Mansoor, GA; Massie, B; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Voors, AA | 1 |
1 review(s) available for rolofylline and Dyspnea
Article | Year |
---|---|
Acute decompensated heart failure: update on new and emerging evidence and directions for future research.
Topics: Adrenomedullin; Atrial Natriuretic Factor; Biomarkers; Blood Pressure Monitoring, Ambulatory; Cardiotonic Agents; Clinical Trials as Topic; Diet, Sodium-Restricted; Diuretics; Dopamine; Dose-Response Relationship, Drug; Dyspnea; Glycopeptides; Heart Failure; Hemofiltration; Hospitalization; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Peptide Fragments; Prognosis; Protein Precursors; Quality of Health Care; Relaxin; Risk Assessment; Saline Solution, Hypertonic; Urea; Vasodilator Agents; Xanthines | 2013 |
4 trial(s) available for rolofylline and Dyspnea
Article | Year |
---|---|
Diuretic response in acute heart failure: clinical characteristics and prognostic significance.
Topics: Acute Disease; Aged; Analysis of Variance; Atherosclerosis; Bumetanide; Diabetes Complications; Diuretics; Dose-Response Relationship, Drug; Drug Resistance; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hypotension; Male; Patient Readmission; Renal Insufficiency; Sulfonamides; Torsemide; Treatment Outcome; Weight Loss; Xanthines | 2014 |
The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment.
Topics: Acute Disease; Adenosine A1 Receptor Antagonists; Aged; Cardiovascular Agents; Confidence Intervals; Disease Progression; Diuresis; Dyspnea; Female; Heart Failure; Humans; Male; Pilot Projects; Renal Insufficiency; Risk; Risk Factors; Xanthines | 2008 |
Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study.
Topics: Aged; Diuretics; Dyspnea; Europe; Female; Health Status Indicators; Heart Failure; Hospitalization; Humans; Italy; Length of Stay; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prognosis; Treatment Outcome; Xanthines | 2010 |
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study.
Topics: Acute Disease; Adenosine A1 Receptor Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Dyspnea; Female; Heart Failure; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Prospective Studies; Treatment Outcome; Xanthines | 2011 |
1 other study(ies) available for rolofylline and Dyspnea
Article | Year |
---|---|
Beyond dyspnoea as an endpoint in acute heart failure trials.
Topics: Adenosine A1 Receptor Antagonists; Dyspnea; Female; Heart Failure; Humans; Male; Xanthines | 2011 |